Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spectral's EAA debuts in Russia

This article was originally published in Clinica

Executive Summary

Continuing its expansion into new global markets, Canadian IVD company Spectral Diagnostics is to see its endotoxin activity assay (EAA) distributed exclusively in Russia by BB Medical. The deal is a result of an agreement in May between Spectral and Toray Medical – a subsidiary of Japanese chemicals group Toray Industries – in which the Toronto-based company would be granted access to Toray's distributors in various international territories. Aside from Russia, these countries include China, India and Canada. The distributors will sell the EAA as a standalone product, and in combination with Toray's blood purification device, which removes endotoxin from the bloodstream. The EAA is the only FDA-cleared assay for the measurement of endotoxin, the most common mediator of sepsis, and is used to assess a patient's risk of developing the severe form of the disease. Spectral president and CEO Dr Paul Walker indicated that severalmore distribution agreements in new geographic territories would follow.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042443

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel